Status:
COMPLETED
Ultrasound and Attenuation Imaging
Lead Sponsor:
Hywel Dda Health Board
Conditions:
Non-Alcoholic Fatty Liver Disease
Non Alcoholic Fatty Liver
Eligibility:
All Genders
18+ years
Brief Summary
Fatty liver disease affects almost a 3rd of the United Kingdom (UK) population. Currently, this is being investigated using a type of MRI scan that reports how fatty or not a person's liver is, with a...
Detailed Description
Non-alcoholic fatty liver disease (NAFLD) affects almost a 3rd of the population of the UK and current best practice is to evaluate this using Magnetic Resonance Imaging proton density fat fraction (M...
Eligibility Criteria
Inclusion
- 18 years old or over
- General Practitioner (GP) and Outpatients (OP) referral
- NAFLD, Unknown, Diabetes, Other metabolic disease
Exclusion
- Younger than 18 years old
- Inpatients
- Known large liver masses
- Poor visualisation of the liver due to body type or anatomy.
Key Trial Info
Start Date :
February 14 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 11 2024
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT06552377
Start Date
February 14 2024
End Date
April 11 2024
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bronglais Hospital
Aberystwyth, Ceredigion, United Kingdom, SY23 1ER